Press Room

Event

12th DPI China Technology Conference

Start
Thursday, March 27, 2025 - 09:00
End
Friday, March 28, 2025 - 18:00
Location: Nanjing, China
DPI China 2025

Looking for a complete One-Site Solution for your inhalation and nasal therapies? 
Meet Hovione at the 12th DPI China Technology Conference! 

Hovione offers customized high-performance APIs, particle engineering and formulation along with a full range of highly specialized, patented, and innovative devices, all in one site. 

Don’t miss the chance to speak with our Inhalation Experts in Nanjing. Our team is ready to share how this integration on a single site can support your project.

Session Title:
From Particle to Drug Delivery: Integrated Platforms for Respiratory Drug Products
March 28th, 2025
Session III, 11:30 -12:00

Speaker: 
João Pires, PhD - RD Senior Manager, Inhalation and Advanced Drug Delivery at Hovione

Description: This presentation covers the latest trends in pulmonary and nasal formulations and explores how Hovione’s integrated approach addresses the challenges in developing new therapeutics. From innovative formulation and device platforms to a unique set of expertise and capabilities, the session will guide the audience through the drug development cycle of dry powder formulations. It will highlight how an integrated strategy - encompassing formulation, process, and device optimization - can lead to better and more robust respiratory drug products.

Key learnings:

  • Discover the latest advancements in formulation, particle design, and device platforms that address the growing complexity of respiratory formulations and enable next-generation therapeutics
  • Learn how a seamless integration of formulation, process, and device in the drug development cycle can streamline development, reduce risks, and achieve better products

Delivering solutions every breath of the way.

We live and breathe innovation for the successful delivery of your inhalation and nasal therapies.

Schedule a meeting today.

 

 

 

Also in the Press Room

See All

Every year, the largest bank in Portugal, Caixa Geral de Depósitos recognizes some of Portugal’s brightest young minds through the Caixa +Mundo Awards, providing nearly €800,000 in scholarships to students as they pursue higher education. In this year´s edition, Caixa named the award bestowed upon students pursuing science for Diane Villax. This prestigious honor places Diane Villax among the award’s namesakes – a distinguished group of prominent personalities who have made notable contributions to Portugal´s socio-economic, cultural, political and scientific development over the last 50 years, such as António Ramalho Eanes, Mário Soares, José Saramago, Sophia de Mello Breyner, Leonor Beleza, Elvira Fortunato, Rui Nabeiro, Américo Amorim, and José Manuel de Mello. Diane Villax will also honor the seven scientific award winners by personally meeting with each of them, and following their journeys as future innovators and leaders. But this honor is about far more than one individual. It is a celebration of an entire organization and the people behind it. For 67 years, generations of dedicated teams have worked together with passion, purpose, and excellence to manufacture life-saving medicines and advance science that has a real impact on people. This recognition belongs to all of us.    

News

Prestigious Caixa +Mundo Award named in honor of Diane Villax

May 14, 2026

CDMO Hovione and Industrial Design Consultancy (IDC) have announced that their new single-use capsule-based nasal delivery device is now available exclusively as part of an integrated platform that includes Hovione’s intranasal drug development and manufacturing services. The companies partnered in 2023 with plans for development of two capsule-based devices for intranasal delivery: the single-use device and a multidose device. Read the full article at OINDPnews.com      

Press Clipping
OINDP - Orally inhaled and nasal drug products news, May 11, 2026

Hovione and IDC announce new single-use capsule-based intranasal delivery device for dry powder formulations

May 11, 2026

Integrated approach simplifies development, reduces risk, and supports scalable manufacturing. Hovione and Industrial Design Consultancy Ltd.’s (IDC) lead single-use nasal dry powder device is now available for commercial partnerships. Hovione and IDC have completed the device design and established initial device manufacturing and supply capability, enabling pharmaceutical partners to leverage existing capsule filling infrastructure. This approach simplifies development, reduces cost and risk, and helps shorten timelines to the clinic and commercialization. “This milestone marks an important step in the evolution of our collaboration with IDC — from device innovation to a fully integrated intranasal drug delivery platform,” said Márcio Temtem, Ph.D., Vice President, Strategic Business Management, Hovione. “As the industry looks for faster, more reliable ways to bring complex therapies to patients, integration becomes critical. By bringing together nasal particle engineering science, formulation manufacturing and filling, and device technologies into a single offering, we enable a more seamless and predictable development journey, accelerating the path to market for intranasal therapies.” The nasal delivery device enables broad and targeted nasal deposition flexibility while delivering maximum usability and reliability. With a patented design and manufacturing process established, the platform is available for partnering with pharmaceutical companies on an exclusive basis as part of Hovione’s integrated offering for inhalation and nasal drug development and manufacturing. Additionally, IDC’s Managing Director, Stephen Knowles Ph.D., said the companies are now “well-advanced” with the development of a multi-use device to support an even wider range of therapies and patient needs. Read the full article at ContractPharma.com    

Press Clipping
Contract Pharma, 7 May 2026

Hovione, IDC Launch Intranasal Drug Delivery Platform

May 07, 2026

Also in Events

See All